Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomonas Infections 1Pancreatic Neoplasms 1Neutropenia 1Neoplasms 1Liver Neoplasms 1Gram-Positive Bacterial Infections 1Fever 1Febrile Neutropenia 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Filgrastim 2Ciprofloxacin 2sargramostim 1pegfilgrastim 1niraparib 1fludarabine phosphate 1flt3 ligand protein 1ceftobiprole medocaril 1Vegetables 1Vancomycin 1Stem Cell Factor 1Moxifloxacin 1Methotrexate 1Gentamicins 1Epoetin Alfa 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Colistin 1Cefepime 1Amoxicillin-Potassium Clavulanate Combination 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neutropenia × Vancomycin × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡